283 related articles for article (PubMed ID: 23902855)
1. Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention.
Gupta RK; Van de Vijver DA; Manicklal S; Wainberg MA
Retrovirology; 2013 Jul; 10():82. PubMed ID: 23902855
[TBL] [Abstract][Full Text] [Related]
2. From modeling to morals: imagining the future of HIV PREP in Lesotho.
Kenworthy NJ; Bulled N
Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
[TBL] [Abstract][Full Text] [Related]
3. Ethical use of antiretroviral resources for HIV prevention in resource poor settings.
Rennie S
Dev World Bioeth; 2013 Aug; 13(2):79-86. PubMed ID: 23724978
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review.
Gourlay A; Birdthistle I; Mburu G; Iorpenda K; Wringe A
J Int AIDS Soc; 2013 Jul; 16(1):18588. PubMed ID: 23870277
[TBL] [Abstract][Full Text] [Related]
5. Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates.
Herrera C; Armanasco N; García-Pérez J; Ziprin P; Olejniczak N; Alcamí J; Nuttall J; Shattock RJ
AIDS; 2016 Apr; 30(7):1015-25. PubMed ID: 26854808
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
Bhana N; Ormrod D; Perry CM; Figgitt DP
Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
[TBL] [Abstract][Full Text] [Related]
7. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
Senise JF; Castelo A; Martínez M
AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
[TBL] [Abstract][Full Text] [Related]
8. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
Haberer JE
Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
[TBL] [Abstract][Full Text] [Related]
9. [HIV infection : Reaching a zero risk of transmission].
Henrard S; Wyndham-Thomas C; Van Vooren JP; Goffard JC
Rev Med Brux; 2016; 37(4):315-321. PubMed ID: 28525231
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral agents in pre-exposure prophylaxis: emerging and advanced trends in HIV prevention.
Yap PK; Loo Xin GL; Tan YY; Chellian J; Gupta G; Liew YK; Collet T; Dua K; Chellappan DK
J Pharm Pharmacol; 2019 Sep; 71(9):1339-1352. PubMed ID: 31144296
[TBL] [Abstract][Full Text] [Related]
11. ARV-based HIV prevention for women - where we are in 2014.
Mastro TD; Sista N; Abdool-Karim Q
J Int AIDS Soc; 2014; 17(3 Suppl 2):19154. PubMed ID: 25224614
[TBL] [Abstract][Full Text] [Related]
12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
13. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.
Heffron R; Ngure K; Mugo N; Celum C; Kurth A; Curran K; Baeten JM
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):116-9. PubMed ID: 22595872
[TBL] [Abstract][Full Text] [Related]
14. Preventing neonatal HIV: a review.
Jaspan HB; Garry RF
Curr HIV Res; 2003 Jul; 1(3):321-7. PubMed ID: 15046256
[TBL] [Abstract][Full Text] [Related]
15. Promise and pitfalls of pre-exposure prophylaxis for female sex workers.
Cowan FM; Delany-Moretlwe S
Curr Opin HIV AIDS; 2016 Jan; 11(1):27-34. PubMed ID: 26633639
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 treatment as prevention: the good, the bad, and the challenges.
Smith K; Powers KA; Kashuba AD; Cohen MS
Curr Opin HIV AIDS; 2011 Jul; 6(4):315-25. PubMed ID: 21646878
[TBL] [Abstract][Full Text] [Related]
17. Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection.
Mofenson LM
Clin Infect Dis; 2010 May; 50 Suppl 3():S130-48. PubMed ID: 20397941
[TBL] [Abstract][Full Text] [Related]
18. Prevention of perinatal HIV I transmission by protease inhibitor based triple drug antiretroviral therapy versus nevirapine as single dose at the time of delivery.
Bendle M; Bajpai S; Choudhary A; Pazare A
J Assoc Physicians India; 2012 Dec; 60():39-44. PubMed ID: 23781668
[TBL] [Abstract][Full Text] [Related]
19. Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda.
Delvaux T; Elul B; Ndagije F; Munyana E; Roberfroid D; Asiimwe A
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):223-30. PubMed ID: 19131884
[TBL] [Abstract][Full Text] [Related]
20. HIV and mitochondrial toxicity in children.
Foster C; Lyall H
J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
